|
WO2020149613A1
|
|
Antibody having improved cytosol-penetrating ability
|
|
KR20190132338A
|
|
Cytosol-Penetrating Antibodies and Uses Thereof
|
|
US2019389910A1
|
|
Cell/tissue-specific cell-penetrating antibodies
|
|
KR20190080809A
|
|
Immunotoxin comprising cytosol-penetrating antibody-fused RNase
|
|
KR20190056340A
|
|
Antibody which internalize into the cytosol of cells and binds to inhibit activated Ras and use thereof
|
|
KR20180116204A
|
|
Endosomal escape motif enabling antibody to escape from endosomes and uses thereof
|
|
CA3025757A1
|
|
Cytosol-penetrating antibody and use thereof
|
|
KR20180129514A
|
|
Cytosol-Penetrating Antibodies and Uses Thereof
|
|
EP3466970A1
|
|
Cytosol-penetrating antibody and use thereof
|
|
KR20170133933A
|
|
Method for inducing conformational changes in the complementarity determining regions of antibody
|
|
KR20170133930A
|
|
Endosomal escape motif enabling antibody to escape from endosomes and uses thereof
|
|
MX2017001010A
|
|
Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same.
|
